Where you live had a lot to do with which COVID-19 vaccine you got.
In over 14 million Medicare beneficiaries, we found really large rural-urban variation in who received Pfizer vs Moderna - out today in @Health_Affairs.
@Brown_SPH@BrownGero
https://t.co/Fi1sgCOygj
🚨New publication! 🚨
Our @IntPharmacoEpi-endorsed review in @AmJEpi evaluates how real-world data is used to study #deprescribing 💊 including exposure measurement and immortal time bias 📈 with recommendations for best practices ✅
📚Read it here: https://t.co/g3dwl45mnd
🔬 How do oncologist networks shape clinical trial referrals?
Smith et al. use Social Network Analysis to uncover referral patterns, revealing insights for better trial design with a novel algorithm.
Read more: https://t.co/MTpIsdt8cL
#Oncology#ClinicalTrials#SNA
🎉 Thrilled to share our latest paper published in the Journal of Clinical Epidemiology! 📈
We describe how we developed guidelines to bring RWE into Canadian regulatory/HTA decisions, using transparent reporting. Original guidance link in QR code below: https://t.co/1nb1Kn5uFw
Check out our paper developing Bayesian methods for causal inference with incomplete outcome and covariates (all doable in @mcmc_stan!):
https://t.co/hZeGJDjERt
Recording of a talk on this at NYU's biostatistics symposium can be found here (4:04:20): https://t.co/qknHZAuSV1
UD researchers have been awarded a $3.9 million grant from @NIHAging to explore links between aging arteries, brain and cognitive decline.
https://t.co/NZLZsFGExB
Congratulations @yalindd on her first first-author paper just published in Vaccine, where rigorously examined the intersection of race and ethnicity, geography, and social deprivation for on-time COVID-19 vaccination! @BrownHSPP https://t.co/phsITHKkQU
🌳 We're growing! The Epi Program at University of Delaware is hiring an open-rank, CT faculty member. If you are passionate about teaching epi, have a knack for SAS and R, and enjoy consulting on biostatistical methods you should apply.
#EpiTwitter
https://t.co/OmTckrMUkP
We are hiring a Research Scientist to help with exciting NIA and PCORI-funded projects! Please share widely with your networks. https://t.co/mKcxyxDY5u
We are hiring! If you want to be part of a team which is revolutionizing how we conduct randomized controlled trials, please apply for the position as a senior researcher/postdoctoral researcher in our team! We need bright team members like you 🫵
@CTCPR_ @BiomedUCPH @UCPH_health
Calling all Canadian drug data nerds! Tired of hunting down DINs? We’ve built an easy-to-use tool that generates a list of DINs by ATC/Name in seconds – no more manual labour. Check it out!
🔗 https://t.co/6sPiZq1Pfs
Share with friends!
👋 #DataScience community, apply now for the @UofT -University of Illinois System Joint Call for Proposal
A competitive seed funding program for collaborative education and research initiatives in the area of data science.
Deadline: November 18
🔗 https://t.co/MwD14ZfLwb
Gabapentinoids continue to be widely prescribed for numerous health conditions, despite limited evidence on their efficacy for off-label uses and their association with serious adverse events. In the US alone, 5.7 million older adults were prescribed gabapentin in 2022.
Read this @nytimes article to hear compelling patient stories and expert opinions on the risks of inappropriate gabapentin use: https://t.co/Oa5HzUf5fd
@paula_span@MikeSteinman@jsross119 @matthew_growdon
In a new collaboration between @Walgreens & @BrownGero, genome sequencing found potentially concerning racial and ethnic variation in the burden of novel SARS-CoV-2 variants using whole genome sequencing on over 18M tests.
@PharmEpi@themoruknow
https://t.co/aFAuEOHrE1
We're hiring a postdoc in the &-Lab at @NUnetsi!
Looking for a curious, collaborative scholar to work on computational social science questions, at the intersection of data justice + network science. Applications ongoing, interviews ~late Sep/early Oct
https://t.co/mugnLLTsJ7